1Denkert C, Kobel M, Pest S,et al.Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.Am J Pathol,2002,160(3):893-903.
2Seo SS, Song YS, Kang DH, et al. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer. Gynecol Oncol,2004,92(3):927-935.
3Li S, Miner K, Fannin R, et al. Cyclooxygenase- 1 and 2 in normal and malignant human ovarian epithelium. Gynecol Oncol,2004,92(2):622-627.
4Ali-Fehmi R, Che M, Khalifeh I, et al. The effect of cyclooxygenase-2 expression on Tumor vascularity in advanced stage ovarian serious carcinoma. Cancer,2003,98(7): 1423-1429.
5Denkert C, Weichert W, Pest S, et al. Overexpression of the embryoniclethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.Cancer Res,2004,64(1): 189-195.
6Farley J, Uyehara C, Hashiro G, et al. Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure.Gynecol Oncol,2004,92(2):596-602.
7Kim HJ, Wu HG, Park IA, et al. High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy.Int J Radiat Oncol Biol Phys,2003, 55(1):16-20.
8Ishiko O, Sumi T, Yoshida H, et al. Association between overexpression of cyclooxygenase-2 and suppression of apoptosis in advanced cancer of the uterine cervix after cyclic balloon-occluded arterial infusion.Oncol Rep,2001,8(6): 1259-1263.
10Ferrandina G,Lauriola L,Zannoni GF, et al.Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer:clinical implications.Br J Cancer,2002,87(10):1145-1152.
同被引文献4
1[2]Subbaramaiah K,Zakim D,WekslerB B,et al.Inhibition of cyclooxy genase:a novel approach to cancer prevention[J].Proc Soc Exp BioMed,1997,216(2):201-210.
2[3]Sheng HM,Shao JY,Morrow JD.Modulation of apoptosis and bcl-2 expression by prostaglandin E2 in human colonic cancer cells[J].Cancer Res,1998,58(7):362-366.
3[4]Yokoyama Y,Sato S,Futagami,et al.Prognostic significance of vascular endothelian growth factor and its receptors in endometrial carcinomar[J].Gyneeol Oncol,2000,77(3):413-418.
4[5]Masferrer JL,Leahy KM,Koki AT,et al.Anti anglogenie and antitumor activities of cyclooxygenase-2 inhibitors[J].J Cancer Res,2000,60(5):1306-1311.
